Evidence map›Paper›PMID 26282390›Full record

ArticleInflammation2016

Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury.

Eyup Burak Sancak, Hakan Turkön, Selma Çukur, Sevilay Erimsah, Alpaslan Akbas, Murat Tolga Gulpinar, Huseyin Toman, Hasan Sahin, Metehan Uzun

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Detection of chlorite, chlorate and perchlorate in ozonated saline.Experimental and therapeutic medicine · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Application of ozone therapy in interventional medicine.Journal of interventional medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eyup Burak SancakDepartment of Urology, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey. eyupburaksancak@comu.edu.tr.
Hakan TurkönDepartment of Biochemistry, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey.
Selma ÇukurDepartment of Pathology, Abant Izzet Baysal University, Faculty of Medicine, Bolu, Turkey.
Sevilay ErimsahDepartment of Histology and Embryology, Abant Izzet Baysal University, Faculty of Medicine, Bolu, Turkey.
Alpaslan AkbasDepartment of Urology, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey.
Murat Tolga GulpinarDepartment of Urology, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey.
Huseyin TomanDepartment of Anesthesiology, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey.
Hasan SahinDepartment of Anesthesiology, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey.
Metehan UzunDepartment of Physiology, Canakkale Onsekiz Mart University, Faculty of Medicine, Canakkale, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical ozone has therapeutic properties as an antimicrobial, anti-inflammatory, modulator of antioxidant defense system. Major ozonated autohemotherapy (MOA) is a new therapeutic approach that is widely used in the treatment of many diseases. The objective of the present study was to determine whether preischemic application of MOA would attenuate renal ischemia-reperfusion injury (IRI) in rabbits. Twenty-four male New Zealand white rabbits were divided into four groups, each including six animals: (1) Sham-operated group, (2) Ozone group (the MOA group without IRI), (3) IR group (60 min ischemia followed by 24 h reperfusion), and (4) IR + MOA group (MOA group). The effects of MOA were examined by use of hematologic and biochemical parameters consisting of neutrophil to lymphocyte ratio (NLR), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), ischemia-modified albumin (IMA), total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI). In addition, the histopathological changes including the tubular brush border loss (TBBL), tubular cast (TC), tubular necrosis (TN), intertubular hemorrhage and congestion (IHC), dilatation of bowman space (DBS), and interstitial inflammatory cells infiltration (IECI) were evaluated. In the IR group, compared to the Sham group, biochemical parameters indicating oxidative stress, NLR, IL-6, TNF-α, IMA, TOS, and OSI have increased. MOA reduced inflammation and oxidative stress parameters. Although TAS values have decreased in the IR group and increased in the MOA-pretreated group, no significant changes in TAS values were detected between the IR and MOA groups. The total score was obtained by summing all the scores from morphological kidney damage markers. The total score has increased with IR damage when compared with the Sham group (13.83 ± 4.30 vs 1.51 ± 1.71; p = 0.002). But, the total score has decreased significantly after application of MOA (5.01 ± 1.49; p = 0.002; compared with the IR group). MOA preconditioning is effective in reducing tissue damage induced in kidney ischemia-reperfusion injury. The protective effect of MOA is mediated via reducing inflammatory response and regulating of reactive oxygen species (ROS). Renal histology also showed convincing evidence regarding MOA's protective nature against kidney injury induced renal ischemia-reperfusion. Consequently, MOA might be helpful in protecting the kidneys from IR-induced damage in humans, probably through the anti-inflammatory effect and reducing the total oxidant status.

Indexed as

Acute Kidney InjuryAnimalsBiomarkersInflammationInterleukin-6LymphocytesMaleNeutrophilsOxidants, PhotochemicalOxidation-ReductionOxidative StressOzoneRabbitsReactive Oxygen SpeciesReperfusion InjurySerum AlbuminBiomarkersInterleukin-6ischemia-modified albuminOxidants, PhotochemicalOzoneReactive Oxygen SpeciesSerum AlbuminSerum Albumin, HumanTumor Necrosis Factor-alphamajor ozonated autohemotherapymedical ozoneneutrophil to lymphocyte ratiorenal ischemia-reperfusion injurytotal oxidant status

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.